The Candidate Tested Positive for THC: A State-by-State Decision Table After Federal Rescheduling Moves

Why Federal Schedule III Rulemaking Splits DOT Compliance From Civilian ADA Exposure

Federal Controlled Substances Act rescheduling moves do not create a single national workplace cannabis rule. They leave DOT zero-tolerance rules untouched while raising disability-accommodation stakes for state-licensed medical patients in civilian seats.

Every week a multi-state recruiter opens a laboratory portal, sees "POSITIVE — Marijuana Metabolite (THC-COOH > 15 ng/mL)" on a post-offer urine screen, and asks HR one deceptively simple question: "Can we pull the offer?" After the Department of Justice and Drug Enforcement Administration's Schedule III rulemaking proceedings under 21 U.S.C. § 812—including April 2026 administrative action recognizing accepted medical utility for state-authorized medical cannabis alongside May 2026 Department of Transportation compliance guidance—giving a single national answer guarantees an unforced legal error.

Separate two federal statutory tracks before looking at state law:

1. DOT 49 CFR Part 40 Safety-Sensitive Roles Remain Strictly Prohibited: Commercial motor vehicle drivers (FMCSA), aviation mechanics and flight crews (FAA), transit operators (FTA), railroad crews (FRA), and pipeline workers (PHMSA) are governed by the Omnibus Transportation Employee Testing Act of 1991 and 49 CFR Part 40. Under 49 CFR § 40.85 and § 40.151(e), marijuana remains a mandatory tested panel, and a Medical Review Officer (MRO) must not verify a THC-positive test as negative based on a state medical-cannabis registry card or federal rescheduling activity unless and until formal Part 40 rulemaking amends the federal testing panel and FDA-approved Schedule III prescription Dispensing standards apply. Letting a THC-positive CDL applicant behind the wheel violates federal safety regulations.
2. Civilian Roles & Rising ADA Accommodation Scrutiny: Historically, employers defeated federal Americans with Disabilities Act (ADA) claims by medical-cannabis patients in a single paragraph citing 42 U.S.C. § 12114(a), which excludes an individual "currently engaging in the illegal use of drugs" when Schedule I status negated any lawful federal supervision. As federal administrative action shifts medical cannabis out of Schedule I criteria—and across more than 20 states whose disability or medical-cannabis statutes (including New Jersey, New York, Connecticut, Pennsylvania, Nevada, Arizona, Minnesota, and Rhode Island) already protect off-duty medical cardholders—summarily rescinding a civilian offer without engaging in an interactive check regarding the underlying medical disability and off-duty timing invites failure-to-accommodate litigation.

Assay Chemistry Is Now Legal Compliance: Parent THC vs. Non-Psychoactive Metabolites

Standard 5-panel urine and hair screens measure inactive carboxy-THC stored in body fat for weeks, not active impairment. In California and Washington, ordering that legacy lab code for a non-exempt hire is itself unlawful.

Audit the exact specimen code on your laboratory requisition contract today. When an applicant consumes legal cannabis on a Saturday evening in Seattle or Los Angeles, psychoactive parent Delta-9-tetrahydrocannabinol (Delta-9 THC) clears blood and oral fluid rapidly (typically within hours to roughly 24 hours). What lingers in urine for 10 to 30 days—and in hair follicles for up to 90 days—is 11-nor-9-carboxy-THC (THC-COOH), an inactive, non-psychoactive lipid-soluble metabolite.

California and Washington wrote that exact biochemical distinction directly into their civil rights and labor statutes:

• California Government Code § 12954 (AB 2188 — 5+ employees): Makes it an unlawful employment practice under FEHA to discriminate against an applicant or employee in hiring, termination, or conditions of employment based upon either (1) off-the-job, away-from-the-workplace cannabis use, or (2) an employer-required drug screening test that has found the person to have non-psychoactive cannabis metabolites in their hair, blood, urine, or other bodily fluids. To run a lawful pre-employment cannabis screen on a non-exempt California hire, the lab panel must test strictly for active psychoactive parent THC (such as an oral-fluid parent-THC panel)—never a standard urine or hair metabolite screen. California's Civil Rights Department actively enforces cannabis hiring boundaries, including its July 2026 $200,000 hiring-practices settlement with Ralphs Grocery Company.
• California's Narrow Statutory Carveouts (§ 12954(c)–(e)): Section 12954 exempts only: (a) employees in the building and construction trades (defined by hands-on construction craft work, not an accountant sitting at a construction firm's headquarters!), (b) positions requiring a federal government background investigation or security clearance under 32 CFR Part 117 / Executive Order 12968, and (c) positions required to be tested under specific state or federal laws (such as DOT Part 40) as a condition of employment, receiving federal funding/licensing, or entering a federal contract. Note carefully: merely holding a federal contract covered by the Drug-Free Workplace Act of 1988 (41 U.S.C. § 8102) does not mandate drug testing and does not exempt ordinary non-clearance staff from § 12954!
• Washington RCW 49.44.240 (1+ employees): Prohibits employers from making a hiring decision based on a pre-employment drug test that detects non-psychoactive cannabis metabolites. Washington's exemptions cover law enforcement, fire departments, public-safety first responders, corrections officers, airline/aerospace safety roles, federal clearance/DOT mandates, and safety-sensitive positions for which impairment while working presents a substantial risk of death—provided the employer identified that safety-sensitive role in writing before the applicant applied for employment (RCW 49.44.240(3)(g)). If you forgot to disclose the safety-sensitive designation prior to application, you cannot invoke that exception after the urine result comes back!

Total Pre-Hire Testing Bans: New York State, NYC, Philadelphia, and Medical-Card States

Switching from urine to oral-fluid parent-THC testing solves California and Washington, yet violates New York and Philadelphia law. Several major jurisdictions ban pre-employment cannabis testing altogether for ordinary roles.

Before your people operations team rolls out a nationwide "4-panel + Oral Fluid Parent THC" order, check the jurisdictions where any pre-employment THC screen is unlawful for standard jobs:

• New York State (N.Y. Lab. Law § 201-d(2)(b) & (4-a)): Per New York Department of Labor MRTA guidance, employers may not test applicants or employees for cannabis at all unless a specific statutory exception under § 201-d(4-a) applies—namely, a mandatory federal/state legal requirement (such as DOT 49 CFR Part 40), loss of a federal contract or federal funding if testing is not run, or observable, articulable on-duty impairment symptoms (which by definition cannot exist on a pre-employment test before Day 1).
• New York City (NYC Admin. Code § 8-107(31)) & Philadelphia (Phila. Code § 9-5500): Both cities flatly prohibit requiring job applicants to submit to pre-employment marijuana/THC testing (urine, hair, blood, or saliva) unless the specific seat falls inside codified safety, CDL, construction-code, child/patient vulnerable-care, or federal-mandate exceptions.
• New Jersey (CREAMMA, N.J.S.A. 24:6I-52): Prohibits refusing to hire or penalizing any person solely because of a positive cannabinoid drug test—unless accompanied by scientifically reliable objective testing plus a physical evaluation by a certified Workplace Impairment Recognition Expert (WIRE) establishing on-the-job impairment (exempting federal mandates/contract loss).

The Five-Step Triage Script Before Any Recruiter Pulls an Offer

Most unlawful rescissions happen when a staffing vendor leaves an antiquated 5-panel urine bundle turned on for remote or multi-state requisitions. Run this five-question gate before speaking to the candidate.

Note one extra procedural intersection: if your drug-testing vendor acts as a third-party consumer reporting agency assembling adjudicated screening reports, coordinate any lawful disqualification with our five-business-day FCRA pre-adverse action calendar (and state split-specimen retest notice laws such as Minnesota, Vermont, Iowa, or New York City carveouts) before finalizing a revocation.

======================================================================
PRE-EMPLOYMENT THC POSITIVE — HR COMPLIANCE TRIAGE WORKSHEET
======================================================================
Candidate Name & Req ID:        [Full Name] · Req #[XXXX]
Physical Work State & City:     [City, State — Check Remote Home Seat!]
Lab Specimen & Analyte Code:    [Urine THC-COOH / Hair / Oral Parent Delta-9]

GATE 1 — FEDERAL STATUTORY MANDATE CHECK
Is this role governed by DOT 49 CFR Part 40, NRC/DOE nuclear rules, or
a federal security clearance (32 CFR Part 117 / EO 12968)?
  -> YES: Federal zero-tolerance applies regardless of state law or
          Schedule III status. Proceed with MRO-verified federal protocol.
  -> NO:  Proceed to Gate 2. (Note: Drug-Free Workplace Act 41 U.S.C.
          § 8102 alone does NOT require drug testing!)

GATE 2 — TOTAL PRE-HIRE THC BAN CHECK (NY / NYC / PHILA / NJ / MN)
Will the candidate work in NY State, NYC, Philadelphia, NJ, or MN (non-exempt)?
  -> YES: STOP RESCISSION. Pre-employment THC disqualification is barred.
          Clear the THC flag and instruct vendor to switch Req to 4-Panel
          (No THC) immediately.
  -> NO:  Proceed to Gate 3.

GATE 3 — METABOLITE ASSAY BAN CHECK (CA § 12954 / WA RCW 49.44.240)
Is the seat in CA (outside hands-on building/construction trades) or WA
(without pre-application written substantial-risk-of-death notice), AND
did the lab test Urine/Hair/Blood for non-psychoactive THC-COOH?
  -> YES: STOP RESCISSION. Disqualifying on non-psychoactive metabolites
          is unlawful. Clear the candidate for onboarding.
  -> NO:  Proceed to Gate 4.

GATE 4 — MEDICAL CARD & ADA / STATE DISABILITY INTERACTIVE CHECK
Has the candidate disclosed a valid state medical-cannabis card or
underlying disability to the MRO or HR?
  -> YES: Open confidential interactive check: confirm strictly off-duty
          use, zero on-shift impairment, and assess any genuine safety-
          critical duty restriction with Legal before any adverse step.
======================================================================

Rebuilding Your Lab Panel Menu Across HR, Vendors, and Line Managers

The cleanest compliance fix for 90% of non-DOT roles is removing THC from default pre-employment panels altogether while strengthening on-shift reasonable-suspicion training.

Every state statute protecting off-duty cannabis—including Cal. Gov. Code § 12954(d), Wash. RCW 49.44.240(4), and N.Y. Lab. Law § 201-d(4-a)—expressly preserves the employer's right to prohibit possession, use, or active impairment on the job or during work hours. Equip floor leaders through manager support to document objective, contemporaneous impairment indicators (slurred speech, unsteady gait, odor of burnt cannabis on clothing during shift, safety near-misses) using two trained witnesses rather than relying on pre-hire urine screens that only police what an accountant did two weekends ago.